StenoCare says France submits medical cannabis reimbursement decree for top court review

Reuters2026/08/07 06:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

StenoCare said France has submitted a draft decree on medical cannabis evaluation, pricing, and reimbursement to the Conseil d’État on July 2, 2026.
Management framed the move as a key step toward a permanent French medical cannabis framework, with reimbursement seen as critical for market viability.
The company said submission is not final approval; the decree still needs legal review, formal adoption, and publication before applications can open.
StenoCare reiterated its ASTRUM 10-10 oil is positioned for the planned framework, with product approvals expected to require French-specific dossiers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. StenoCare A/S published the original content used to generate this news brief via Cision (Ref. ID: 202608070200BITN____UKPR__EN_20260806-BIT-5142-0) on August 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

StenoCare says France submits medical cannabis reimbursement decree for top court review

You may also like

Crypto prices